4//SEC Filing
Foundation Medicine, Inc. 4
Accession 0001209191-17-017389
CIK 0001488613operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:02 PM ET
Size
5.5 KB
Accession
0001209191-17-017389
Insider Transaction Report
Form 4
Daly David
Chief Commercial Officer
Transactions
- Sale
Common Stock
2017-03-01$25.12/sh−541$13,590→ 100,652 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on February 28, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F2]The reporting person previously reported the restricted stock units granted to the reporting person on December 5, 2014 in Table I of the Form 4 filed on December 9, 2014. As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001488613
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:02 PM ET
- Size
- 5.5 KB